secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ovid Therapeutics Inc. (OVID)
CIK:        0001636651
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0000950170-23-027151
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ovid Therapeutics shareholders elect directors, approve say-on-pay, ratify auditor
--------------------------------------------------------------------------------

- Karen Bernstein re-elected with 39.7M for, 5.1M withheld; Jeremy Levin re-elected with 44.5M for, 0.4M withheld (16.5M broker non-votes).
- Say-on-pay approved: 44.7M for, 113,666 against, 40,903 abstain (16.5M broker non-votes).
- Shareholders recommended one-year frequency for say-on-pay (44.0M for one year, 793,928 for three years).
- Ratification of KPMG as auditor for FY2023: 61.2M for, 65,728 against, 2,922 abstain.
- Board determined future say-on-pay votes will be annual until at least 2029.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636651/000095017023027151/0000950170-23-027151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636651/000095017023027151/ovid-20230608.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer